The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
endoc can abono are going to be released in a very specific spatial and temporal manner so they evolve to do that yeah so there's going to be and I think like it's very clear that like anandamide for example is not active at every synapse that has CB1 and so when we boost anandamide signaling by inhibiting its metabolism all we're doing is amplifying anandamide signaling at the synapses it already exists
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.